STUMPTOWN STRATEGIES

Lobbying for PRIME THERAPEUTICS · Healthcare

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Minnesota · House · Senate · $20,000.00 income · posted Jul 21, 2025

Bills named in this filing 1

Lobbying activity 2

Pharmacy

HR 2214 DRUG Act Delinking, PBM Issues

Health Issues

PBM issues - Transparency, Delinking HR 2214 Drug Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.